14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for ONC.TO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.64 2.50 %
R2 1.63 1.78 %
R1 1.62 1.34 %
Current price: 1.60
Support S1 1.60 -0.0913 %
S2 1.59 -0.534 %
S3 1.58 -1.25 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 1.60
Support S1 1.56 -2.50%
S2 1.37 -14.38%
S3 1.21 -24.38%

ONC.TO Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Oncolytics Biotech Inc.

Oncolytics Biotech. Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with ... ONC.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT